Related Experiment Videos
[Benign hepatomata while taking oral contraceptives (author's transl)]
MMW, Munchener Medizinische Wochenschrift
|May 9, 1980
Summary
Oral contraceptives are linked to an increased risk of benign liver tumors (hepatomata). This case study details a 38-year-old woman with focal nodular hyperplasia after 8 years of use, with no recurrence after surgery.
Area of Science:
- Hepatology
- Oncology
- Endocrinology
Background:
- Oral contraceptives (OCs) have been associated with an increased incidence of benign liver tumors, specifically hepatomata.
- Long-term use of hormonal contraceptives requires ongoing monitoring for potential adverse effects on liver health.
Observation:
- A 38-year-old woman presented with a palpable abdominal tumor in the right upper quadrant.
- The patient had a history of 8 years of oral contraceptive use.
Findings:
- Laparotomy revealed multiple liver nodules in both hepatic lobes.
- Histological examination confirmed multicentric focal nodular hyperplasia.
- Surgical resection via wedge incision achieved near-complete removal of the lesions.
Implications:
- Focal nodular hyperplasia is a potential, though rare, complication of long-term oral contraceptive use.
- Surgical management can be effective for symptomatic or large lesions.
- Continued surveillance is crucial to monitor for tumor recurrence or new developments.